retatrutide effects Side Research VisualAbstract: Retatrutide reduces body weight

DOI: 10.1056/NEJMra2500106 4 HbA1c 2% 22% 1426% 2 GLP-1 GLP-1 NEJM 2 1 FAQ MEN2 GLP-1 2 2 BMI35BMI27 2 2BMI27 22 2 MASLD 13 GLP-1 2 GLP-1 100 STEP 1 1920 GLP-1GIP STEP 21990 John EngGLP-1-42005 STEP 3123 GLP-11GLP-1GIP2022GLP-1GIP 19 1920 Banting Best 19701980 GIP KHabenerDruckerHolstBloom GLP-1 L737 1990 John Eng -4 GLP-1GLP-1 2005 DPP-4 2010 1LEADERSUSTAIN 6 2022 GLP-1GIP GLP-1GIP3 GLP-1 GLP-1GIPDPP-44 2 DPP-4 1 GIP GIPK2GLP-1 GIPAKTGLUT4 GLP-1GIP225%3 3 3 GLP-1GIP 3 GIP K GLP-1 GLP-1GGPCRcAMPCaCaEpac2GLP-1 GIP GIPGPCRGLP-1KATPGLP-1GIPAKTBGLUT4LPL GLP-1 GLP-1 NEJM 2026 GLP-1GIPDPP-44GLP-1 GLP-1GLP-1GIP 2 2 GLP-1GIP225% 2 GLP-1 2 1426% SUSTAIN 6SOUL 3 CKD3 18% Lancet Diabetes Endocrinol 2025 FDA20251 2 20264 MACE3CVHFpEF3 LEADERSUSTAIN 6SOUL HFpEF3 522% 5,000 682.4% 723%5.39.6kg15mgtreatment estimand20.9%efficacy estimand22.5% GLP-1+GIP+2 STEP 4 GLP-1 045-864-2110 8 48%8 1.5 RCT 7610GLP-11.5 SURMOUNT-11RCT1,600 521%JAMA Netw Open 2024 EClinicalMedicine 2024 GLP-1 C GLP-1 GLP-1 FDA 2 GLP-1RA10.52mg2SOUL 2.4mg12BMI35BMI272 GLP-1+GIP 12 2025412BMI35BMI272 GLP-1RA1REWIND GLP-1RALEADER FDA20264 GLP-1RA Foundayo 202641 FDA 11 17.2mg 12% ATTAIN-1 50 FDACNPV C Boxed Warning MEN2 CNPV50 CNPVCommissioners National Priority Voucher FDA2025FDA Boxed Warning Boxed Warning FDAFoundayo C MTCMEN2 CNPV2025PMDA 23 NEJM 2026 MASLD 3N Engl J Med 2025 GLP-1 HbA1c 045-864-2110 HbA1c GLP-1 2 GLP-12026 Rosen CJ, Ingelfinger JR

I'm your host, nurse practitioner Cynthia Thurlow

Understanding why bruising occurs and how to minimize it through proper injection technique can significantly improve your treatment experience

Overreliance on a single vendor can lock you into workflows that wont age well

The role of probiotics in personalized therapeutics: advances in gut microbedriven interventions

A: To maintain maximum potency and shelf life, L-Carnitine HCL should be stored in a cool, dry place protected from light